Assistive Reproductive Technology Market, by Product Type (Consumables and Instruments), by Technology (In-vitro fertilization (IVF) (IVF with Intracytoplasmic Sperm Injection (ICSI) and IVF without Intracytoplasmic Sperm Injection (ICSI), Artificial Ins

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,500	170 Pages	Coherent Market Insights	May, 2022	CMI17211688

Best Price Guarantee
Price	from $4,500
Length	170 Pages
Publisher	Coherent Market Insights
Published Date	May, 2022
SKU	CMI17211688

Assistive Reproductive Technology Market, by Product Type (Consumables and Instruments), by Technology (In-vitro fertilization (IVF) (IVF with Intracytoplasmic Sperm Injection (ICSI) and IVF without Intracytoplasmic Sperm Injection (ICSI), Artificial Insemination-Intrauterine Insemination (AI-IUI), Frozen Embryo Replacement (FER) and Others); by Procedure (Fresh Donor, Frozen Donor, Fresh Nondonor, Frozen Nondonor, Embryo/Egg Banking, and Others; by End User (Fertility Clinics, IVF Center, and Hospital), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Assistive reproductive technology (ART) is an infertility treatment procedure. In this procedure, the sperm and eggs are taken out of the body and oocyte fertilization is done under laboratory environment. The fertilization process carried outside the body is known as In vitro fertilization (IVF). There are mainly two type of IVF procedures such IVF with Intracytoplasmic Sperm Injection (ICSI) and IVF without Intracytoplasmic Sperm Injection (ICSI).
Market Dynamics
Increase in infertility rates over the past years has supported growth of global assistive reproductive technologies market growth. For instance, according to the European society of Human Reproduction and Embryology (ESHRE) in 2021, more than 8 million babies, were born from IVF procedure. This rising number of IVF procedures is expected to boost the global assistive reproductive technology market growth.
Rising prevalence of infertility cases has led to an increase in demand for ART treatment techniques. Furthermore, higher rate of successful pregnancies and births resulting from ART cycles using fresh nondonor eggs or embryos is expected to facilitate the market growth. For instance, in 2016, as per IVF birth rate statistics, around 6.5 million babies were born using in-vitro fertilization (IVF). Moreover, according to the Centers for Disease Control and Prevention (CDC), around 1.6 percent of babies born in the United States each year are conceived through assisted reproductive technology (ART).
ART cycles, are carried out using various procedures such as fresh donor, frozen donor, fresh nondonor, frozen nondonor and embryo/egg banking. The choice of procedures also affects growth of the assistive reproductive technology market, depending upon the type of technology procedures are also chosen. In 2015, according to Centers for Disease Control and Prevention (CDC) 26% fresh nondonor and 42% frozen nondonor procedures were performed in the U.S. These factors are expected to propel the global assistive reproductive technology market growth.
Restraints of the Global Assistive Reproductive Technology Market
One of the major restraints of this market is the issue of legal parental rights, and few concern of people such as, whose names will be there on birth certificate and who will have parental responsibility. Such factors may refrain parents to make use of assistive reproductive technologies.
Key features of the study:
This report provides in-depth analysis of the global assistive reproductive technology market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global assistive reproductive technology market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
Key companies covered as a part of this study include Cooper Surgical Inc., Hamilton Thorne, Inc., FUJIFILM Irvine Scientific, Inc., Merck KGaA, Nidacon International AB, Vitrolife AB, EMD Serono, Inc., INVO Bioscience, IVFtech ApS, Gonagen Medikal, Cook Medical Llc., and CellCura ASA
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global assistive reproductive technology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the assistive reproductive technology market.
Detailed Segmentation
Global Assistive Reproductive Technology Market, By Product Type:
Consumables
Instruments
Global Assistive Reproductive Technology Market, By Technology:
In-vitro fertilization (IVF)
IVF with Intracytoplasmic Sperm Injection (ICSI)
IVF without Intracytoplasmic Sperm Injection (ICSI)
Artificial Insemination-Intrauterine Insemination (AI-IUI)
Frozen Embryo Replacement (FER)
Others
Global Assistive Reproductive Technology Market, By Procedure:
Fresh Donor
Frozen Donor
Fresh Nondonor
Frozen Nondonor
Embryo/Egg Banking
Others
Global Assistive Reproductive Technology Market, By End User:
Fertility Clinics
IVF Center
Hospital
Global Assistive Reproductive Technology Market, By Region:
North America
By Product Type :
Consumables
Instruments
By Technology:
In-vitro fertilization (IVF)
IVF with Intracytoplasmic Sperm Injection (ICSI)
IVF without Intracytoplasmic Sperm Injection (ICSI)
Artificial Insemination-Intrauterine Insemination (AI-IUI)
Frozen Embryo Replacement (FER)
Others
By Procedure :
Fresh Donor
Frozen Donor
Fresh Nondonor
Frozen Nondonor
Embryo/Egg Banking
Others
By End User:
Fertility Clinics
IVF Center
Hospital
By Country:
U.S.
Canada
Europe
By Product Type :
Consumables
Instruments
By Technology:
In-vitro fertilization (IVF)
IVF with Intracytoplasmic Sperm Injection (ICSI)
IVF without Intracytoplasmic Sperm Injection (ICSI)
Artificial Insemination-Intrauterine Insemination (AI-IUI)
Frozen Embryo Replacement (FER)
Others
By Procedure :
Fresh Donor
Frozen Donor
Fresh Nondonor
Frozen Nondonor
Embryo/Egg Banking
Others
By End User:
Fertility Clinics
IVF Center
Hospital
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Product Type :
Consumables
Instruments
By Technology:
In-vitro fertilization (IVF)
IVF with Intracytoplasmic Sperm Injection (ICSI)
IVF without Intracytoplasmic Sperm Injection (ICSI)
Artificial Insemination-Intrauterine Insemination (AI-IUI)
Frozen Embryo Replacement (FER)
Others
By Procedure :
Fresh Donor
Frozen Donor
Fresh Nondonor
Frozen Nondonor
Embryo/Egg Banking
Others
By End User:
Fertility Clinics
IVF Center
Hospital
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
By Product Type :
Consumables
Instruments
By Technology:
In-vitro fertilization (IVF)
IVF with Intracytoplasmic Sperm Injection (ICSI)
IVF without Intracytoplasmic Sperm Injection (ICSI)
Artificial Insemination-Intrauterine Insemination (AI-IUI)
Frozen Embryo Replacement (FER)
Others
By Procedure :
Fresh Donor
Frozen Donor
Fresh Nondonor
Frozen Nondonor
Embryo/Egg Banking
Others
By End User:
Fertility Clinics
IVF Center
Hospital
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
By Product Type :
Consumables
Instruments
By Technology:
In-vitro fertilization (IVF)
IVF with Intracytoplasmic Sperm Injection (ICSI)
IVF without Intracytoplasmic Sperm Injection (ICSI)
Artificial Insemination-Intrauterine Insemination (AI-IUI)
Frozen Embryo Replacement (FER)
Others
By Procedure :
Fresh Donor
Frozen Donor
Fresh Nondonor
Frozen Nondonor
Embryo/Egg Banking
Others
By End User:
Fertility Clinics
IVF Center
Hospital
By Country:
GCC
Israel
Rest of Middle East
Africa
By Product Type :
Consumables
Instruments
By Technology:
In-vitro fertilization (IVF)
IVF with Intracytoplasmic Sperm Injection (ICSI)
IVF without Intracytoplasmic Sperm Injection (ICSI)
Artificial Insemination-Intrauterine Insemination (AI-IUI)
Frozen Embryo Replacement (FER)
Others
By Procedure :
Fresh Donor
Frozen Donor
Fresh Nondonor
Frozen Nondonor
Embryo/Egg Banking
Others
By End User:
Fertility Clinics
IVF Center
Hospital
By Country/Region:
Central Africa
South Africa
North Africa
Company Profiles
Cooper Surgical Inc.*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Hamilton Thorne, Inc.
FUJIFILM Irvine Scientific, Inc.
Nidacon International AB
Vitrolife AB
EMD Serono, Inc.
INVO Bioscience
IVFtech ApS
Gonagen Medikal
Cook Medical LLC
CellCura ASA
Merck KGaA
“*” marked represents similar segmentation in other categories in the respective section.

1. Research Objective and Assumption: Research Objectives; Assumptions; Abbreviations
2. Market Purview: Report Description; Market Definition and Scope; Executive Summary; Market Snippet, By Product Type; Market Snippet, By Technology; Market Snippet, By Procedure; Market Snippet, By End User; Market Snippet, By Region; Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis: Market Dynamics; Drivers; Restraints; Market Opportunities; Impact Analysis; Novel Product Launch/Approval; Acquisitions and Partnerships; Technological Advancement; Regulatory Scenario; Reimbursement Scenario; Product Recalls; PEST Analysis; PORTER’s Analysis; Epidemiology
4. Global Assistive Reproductive Technology Market, By Product Type, 2017 - 2028 (US$ Mn): Introduction; Market Share Analysis, 2022 and 2028(%); Y-o-Y Growth Analysis, 2017 - 2028; Segment Trends; Consumables; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn); Segment Trends; Instruments; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn); Segment Trends
5. Global Assistive Reproductive Technology Market, By Technology, 2017 - 2028 (US$ Mn): Introduction; Market Share Analysis, 2022 and 2028(%); Y-o-Y Growth Analysis, 2017 - 2028; Segment Trends; In-vitro fertilization (IVF); Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn); IVF with Intracytoplasmic Sperm Injection (ICSI); IVF without Intracytoplasmic Sperm Injection (ICSI); Artificial Insemination-Intrauterine Insemination (AI-IUI); Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn); Frozen Embryo Replacement (FER); Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn); Others; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
6. Global Assistive Reproductive Technology Market, By Procedures, 2017 - 2028 (US$ Mn): Introduction; Market Share Analysis, 2022 and 2028(%); Y-o-Y Growth Analysis, 2017 - 2028; Segment Trends; Fresh Donor; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn); Frozen Donor; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn); Fresh Nondonor; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn); Embryo/Egg Banking; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn); Others; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
7. Global Assistive Reproductive Technology Market, By End User, 2017 - 2028 (US$ Mn): Introduction; Market Share Analysis, 2022 and 2028(%); Y-o-Y Growth Analysis, 2017 - 2028; Segment Trends; Fertility Clinics; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn); IVF Center; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn); Hospital; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
8. Global Assistive Reproductive Technology Market, By Region, 2017 - 2028 (US$ Mn): Introduction; Market Share Analysis, By Region, 2022 and 2028(%); Y-o-Y Growth Analysis, For Regions, 2017 - 2028; North America; Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn); Market Size and Forecast, By Technology, 2017 - 2028 (US$ Mn); Market Size and Forecast, By Procedure, 2017 - 2028 (US$ Mn); Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn); Market Size and Forecast, By Region, 2017 - 2028 (US$ Mn); U.S.; Canada; Europe; Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn); Market Size and Forecast, By Technology, 2017 - 2028 (US$ Mn); Market Size and Forecast, By Procedure, 2017 - 2028 (US$ Mn); Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn); Market Size and Forecast, By Region, 2017 - 2028 (US$ Mn); U.K.; Germany; Italy; France; Spain; Russia; Rest of Europe; Asia Pacific; Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn); Market Size and Forecast, By Technology, 2017 - 2028 (US$ Mn); Market Size and Forecast, By Procedure, 2017 - 2028 (US$ Mn); Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn); Market Size and Forecast, By Region, 2017 - 2028 (US$ Mn); China; India; Japan; ASEAN; Australia; South Korea; Rest of Asia Pacific; Latin America; Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn); Market Size and Forecast, By Technology, 2017 - 2028 (US$ Mn); Market Size and Forecast, By Procedure, 2017 - 2028 (US$ Mn); Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn); Market Size and Forecast, By Region, 2017 - 2028 (US$ Mn); Brazil; Mexico; Argentina; Rest of Latin America; Africa; Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn); Market Size and Forecast, By Technology, 2017 - 2028 (US$ Mn); Market Size and Forecast, By Procedure, 2017 - 2028 (US$ Mn); Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn); Market Size and Forecast, By Region, 2017 - 2028 (US$ Mn); Central Africa; South Africa; North Africa; Middle East; Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn); Market Size and Forecast, By Technology, 2017 - 2028 (US$ Mn); Market Size and Forecast, By Procedure, 2017 - 2028 (US$ Mn); Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn); Market Size and Forecast, By Region, 2017 - 2028 (US$ Mn); GCC; Israel; Rest of Middle East
9. Competitive Landscape: Heat Map Analysis; Company Profiles; Cooper Surgical Inc.; Company Overview; Product Portfolio; Key Developments; Financial Performance; Strategies; Hamilton Thorne, Inc.; Company Overview; Product Portfolio; Key Developments; Financial Performance; Strategies; FUJIFILM Irvine Scientific, Inc.; Company Overview; Product Portfolio; Key Developments; Financial Performance; Strategies; Nidacon International AB; Company Overview; Product Portfolio; Key Developments; Financial Performance; Strategies; Vitrolife AB; Company Overview; Product Portfolio; Key Developments; Financial Performance; Strategies; EMD Serono, Inc.; Company Overview; Product Portfolio; Key Developments; Financial Performance; Strategies; INVO Bioscience; Company Overview; Product Portfolio; Key Developments; Financial Performance; Strategies; IVFtech ApS; Company Overview; Product Portfolio; Key Developments; Financial Performance; Strategies; Gonagen Medikal; Company Overview; Product Portfolio; Key Developments; Financial Performance; Strategies; Cook Medical LLC.; Company Overview; Product Portfolio; Key Developments; Financial Performance; Strategies; CellCura ASA; Company Overview; Product Portfolio; Key Developments; Financial Performance; Strategies; Merck KGaA; Company Overview; Product Portfolio; Key Developments; Financial Performance; Strategies
10. Section: References; Research Methodology; About us and Sales Contact; *Browse 37 market data tables and 25 figures on “Assistive Reproductive Technology Market - Global forecast to 2028.